BACKGROUND AND OBJECTIVES: Diagnosis of acute myocardial injury with biomarkers is difficult in patients with advanced renal failure. Circulating microRNAs are promising new biomarkers of myocardial injury. It is unknown whether levels of microRNAs are affected in patients undergoing hemodialysis. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: High-sensitivity cardiac troponin T (hsTnT) and cardiac-enriched miR-499 were measured in 41 patients with ESRD undergoing hemodialysis and 41 controls. RESULTS: Levels of hsTnT and miR-499 were highly elevated in patients with ESRD compared with controls (>80-fold increase; P<0.001). Among patients with ESRD, 98% had positive hsTnT levels and 46% had positive miR-499 levels. Levels of troponins were not affected by hemodialysis. However, miR-499 levels were decreased after hemodialysis (6.5-fold decrease; P=0.002). CONCLUSIONS: Both miR-499 and troponins are elevated in patients with advanced renal failure. However, whereas levels of troponins are unaffected by hemodialysis, this is not the case for miR-499. Therefore, these observations mitigate the potential of miR-499 as a marker of myocardial injury in patients with ESRD.
BACKGROUND AND OBJECTIVES: Diagnosis of acute myocardial injury with biomarkers is difficult in patients with advanced renal failure. Circulating microRNAs are promising new biomarkers of myocardial injury. It is unknown whether levels of microRNAs are affected in patients undergoing hemodialysis. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: High-sensitivity cardiac troponin T (hsTnT) and cardiac-enriched miR-499 were measured in 41 patients with ESRD undergoing hemodialysis and 41 controls. RESULTS: Levels of hsTnT and miR-499 were highly elevated in patients with ESRD compared with controls (>80-fold increase; P<0.001). Among patients with ESRD, 98% had positive hsTnT levels and 46% had positive miR-499 levels. Levels of troponins were not affected by hemodialysis. However, miR-499 levels were decreased after hemodialysis (6.5-fold decrease; P=0.002). CONCLUSIONS: Both miR-499 and troponins are elevated in patients with advanced renal failure. However, whereas levels of troponins are unaffected by hemodialysis, this is not the case for miR-499. Therefore, these observations mitigate the potential of miR-499 as a marker of myocardial injury in patients with ESRD.
Authors: J Dierkes; U Domröse; S Westphal; A Ambrosch; H P Bosselmann; K H Neumann; C Luley Journal: Circulation Date: 2000-10-17 Impact factor: 29.690
Authors: Yvan Devaux; Mélanie Vausort; Emeline Goretti; Petr V Nazarov; Francisco Azuaje; Georges Gilson; Maarten F Corsten; Blanche Schroen; Marie-Lise Lair; Stephane Heymans; Daniel R Wagner Journal: Clin Chem Date: 2012-01-17 Impact factor: 8.327
Authors: Benjamin J Freda; W H Wilson Tang; Frederick Van Lente; W Franklin Peacock; Gary S Francis Journal: J Am Coll Cardiol Date: 2002-12-18 Impact factor: 24.094
Authors: Filippo Martino; Johan Lorenzen; Julius Schmidt; Mascha Schmidt; Michael Broll; Yvonne Görzig; Jan T Kielstein; Thomas Thum Journal: PLoS One Date: 2012-06-08 Impact factor: 3.240
Authors: Ping Wen; Dan Song; Hong Ye; Xiaochun Wu; Lei Jiang; Bing Tang; Yang Zhou; Li Fang; Hongdi Cao; Weichun He; Yafang Yang; Chunsun Dai; Junwei Yang Journal: PLoS One Date: 2014-10-14 Impact factor: 3.240
Authors: Marcin Dziedzic; Tomasz Powrózek; Ewelina Orłowska; Wojciech Koch; Wirginia Kukula-Koch; Kinga Gaweł; Anna Bednarek-Skublewska; Teresa Małecka-Massalska; Janusz Milanowski; Beata Petkowicz; Janusz Solski Journal: PLoS One Date: 2017-06-14 Impact factor: 3.240
Authors: Lobna Abdelsalam; Alshaymaa A Ibrahim; Aliaa Shalaby; Noha Osman; Assem Hashad; Dina Badawy; Hany Elghobary; Eman Amer Journal: Arch Med Sci Date: 2019-08-08 Impact factor: 3.318
Authors: Laura Rivoli; A D Bastiaan Vliegenthart; Carmelita M J de Potter; Job J M H van Bragt; Nikolaos Tzoumas; Peter Gallacher; Tariq E Farrah; Neeraj Dhaun; James W Dear Journal: Br J Clin Pharmacol Date: 2016-10-21 Impact factor: 4.335
Authors: Neal X Chen; Kraiwiporn Kiattisunthorn; Kalisha D O'Neill; Xianming Chen; Ranjani N Moorthi; Vincent H Gattone; Matthew R Allen; Sharon M Moe Journal: PLoS One Date: 2013-05-22 Impact factor: 3.240